Margherita Fabbri Selected Research

Drug Tapering

1/2022

COMT Inhibitors in the Management of Parkinson's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Margherita Fabbri Research Topics

Disease

35	Parkinson Disease (Parkinson's Disease) 05/2022 - 09/2014
10	Dyskinesias (Dyskinesia) 05/2022 - 10/2014
4	Disease Progression 01/2017 - 10/2014
2	Movement Disorders (Movement Disorder) 05/2022 - 12/2021
2	Pain (Aches) 05/2022 - 01/2017
2	Sleepiness 03/2022 - 01/2017
2	Orthostatic Hypotension (Postural Hypotension) 01/2022 - 01/2017
2	Multiple System Atrophy 01/2022 - 01/2021
2	Parkinsonian Disorders (Parkinsonism) 12/2021 - 09/2014
2	Deglutition Disorders (Dysphagia) 01/2020 - 01/2019
1	Sudden Death 01/2022
1	Camptocormia 01/2022
1	Huntington Disease (Huntington's Disease) 12/2021
1	Tardive Dyskinesia 12/2021
1	Hallucinations (Hallucination) 01/2020
1	Dysarthria (Spastic Dysarthria) 01/2019
1	Psychotic Disorders (Schizoaffective Disorder) 01/2019
1	Fatigue 01/2017
1	Body Weight (Weight, Body) 10/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2014
1	Dystonia (Limb Dystonia) 07/2014
1	Glioma (Gliomas) 06/2014
1	Autosomal Dominant Lateral Temporal Lobe Epilepsy 06/2014
1	Fatal Familial Insomnia 03/2014
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 03/2014

Drug/Important Bio-Agent (IBA)

17	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 10/2014
6	Carbidopa (Lodosyn)FDA LinkGeneric 05/2021 - 08/2019
5	Pharmaceutical PreparationsIBA 01/2022 - 10/2014
3	catechol (pyrocatechol)IBA 01/2022 - 10/2016
3	TransferasesIBA 01/2022 - 10/2016
3	opicaponeIBA 01/2021 - 10/2016
2	safinamideIBA 05/2022 - 12/2015
2	hydroxide ionIBA 01/2022 - 01/2017
2	Amantadine (Aman)FDA LinkGeneric 12/2021 - 01/2020
2	Tolcapone (Tasmar)FDA Link 06/2021 - 10/2016
2	neuromelaninIBA 01/2017 - 01/2017
1	diadenosine triphosphate (ApppA)IBA 01/2022
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 06/2021
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2021
1	SilverIBA 10/2020
1	propylene diquat (PDQ(+))IBA 01/2020
1	Delayed-Action PreparationsIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Carboxy-LyasesIBA 10/2016
1	entacapone (Comtan)FDA Link 10/2016
1	ArylsulfatasesIBA 09/2014
1	Proteins (Proteins, Gene)FDA Link 09/2014
1	Botulinum Toxins (Botulinum Toxin)IBA 07/2014
1	Leucine (L-Leucine)FDA Link 06/2014
1	Prion ProteinsIBA 03/2014

Therapy/Procedure

10	Therapeutics 05/2022 - 07/2014
6	Deep Brain Stimulation 05/2022 - 08/2017
2	Activities of Daily Living (ADL) 05/2022 - 01/2017
1	Oral Administration 01/2022
1	Drug Tapering 01/2022
1	Physical Therapy Modalities (Physical Therapy Technique) 12/2021
1	Duration of Therapy 11/2020
1	Institutionalization (Institutionalized Persons) 01/2019